Nephrology Medical News about renal cell carcinoma, adrenomedullin, CLR, RAMP2/RAMP3

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear-cell renal carcinoma
International Journal of Cancer, 07/29/09

Deville JL et al. - In a trial to determine expression and role of adrenomedullin (AM) in renal tumors and value of its mRNA levels as prognostic factor in clear-cell renal carcinoma (cRCC), these findings highlight the implication of the AM pathway in the metastatic process and the prognostic relevance of AM in cRCC and point to a potential new therapeutic target.

Methods

AM is highly expressed in several tumors and plays an important role in angiogenesis and tumor growth through its receptors: calcitonin receptor-like receptor/receptor activity-modifying protein 2 and 3 (CLR/RAMP2 and CLR/RAMP3).

Results

Real-time quantitative reverse-transcription-PCR showed AM mRNA levels were higher in cRCC and in chromophobe renal carcinomas (chRCC) than in normal renal tissue.
AM mRNA expression in cRCC correlated strongly with VEGF-A mRNA expression.
Immunohistochemically, AM, CLR and RAMP2 were localized in the carcinomatous epithelial compartment of cRCC.
RAMP3 immunostaining was found only in the inflammatory cells that infiltrated tumors, suggesting a cross talk between tumor cells and the microenvironment.
cRCC cells BIZ and 786-O expressed and secreted AM into the culture medium.
In vitro, exogenous AM treatment stimulated cell proliferation, migration and invasion, indicating the cell can respond to AM.
The action of AM was specific and was mediated by the CLR/RAMP2 and CLR/RAMP3 receptors.
Clinical data showed the prognostic value of AM.
High AM mRNA levels were associated with an increased risk of relapse after curative nephrectomy for cRCC.

<< Previous
Giant Angiomyolipoma Associated With a Dilated Vessel Prone to...

Next >>
Laparoscopic Simultaneous Treatment of Peripelvic Renal Cysts and...